Clinical Trials Directory

Trials / Completed

CompletedNCT07145892

Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography

Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography: Which Get the Supremacy in Diagnosis of Benign Breast Lesions in Asymptomatic Females

Status
Completed
Phase
Study type
Observational
Enrollment
255 (actual)
Sponsor
The General Authority for Teaching Hospitals and Institutes · Network
Sex
Female
Age
30 Years
Healthy volunteers
Not accepted

Summary

This study aimed to compare the supremacy of (3D) tomosynthesis versus (2D) digital mammography in the diagnosis of benign breast lesions in asymptomatic females.

Detailed description

Most of the breast lesions are benign, but much concern is given to malignant lesions because breast cancer is the most common malignancy in women. Mammography is the only study for screening in asymptomatic patients, and it is the initial imaging study in the diagnosis of symptomatic patients, with a sensitivity for suspicious lesions of 86% and a specificity of 57%. In recent years, a significant effort has been expended to develop new approaches to breast imaging, one of which is the use of digital breast tomosynthesis (DBT), which is a pseudo three-dimensional digital mammography system that produces a series of thin-section reconstructed images from low-dose X-ray projections at multiple angles.

Conditions

Interventions

TypeNameDescription
DEVICEThree-dimensional Digital Breast TomosynthesisPatients underwent three-dimensional digital breast tomosynthesis.
DEVICETwo-dimensional Digital MammographyPatients underwent two-dimensional digital mammography

Timeline

Start date
2024-06-01
Primary completion
2025-05-29
Completion
2025-05-29
First posted
2025-08-28
Last updated
2025-08-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07145892. Inclusion in this directory is not an endorsement.